Skip to content

Reperfusion Syndrome in liver transplant

Post Reperfusion Syndrome in living donor liver transplant: a prospective study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/08/026979
Enrollment
346
Registered
2020-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K77- Liver disorders in diseases classified elsewhere

Interventions

None listed

Sponsors

Center for liver and Biliary Sciences Max Super Speciality Hospital SaketNew DelhiIndia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All consecutive LT procedures in adult patients in our unit will be enrolled for collection of data

Exclusion criteria

Exclusion criteria: 1. All Deceased - donor related transplantation (DDLTs) 2. Liver transplants done in patients with ALF 3. LT for non-cirrhotic liver disease 4. Combined liver/kidney transplantation 5. Re-transplantation 6. All liver recipients identified to have cirrhotic cardiomyopathy, grade 3 Diastolic dysfunction on routine preoperative evaluation. 7. All LT recipients on Inotropes before surgery

Design outcomes

Primary

MeasureTime frame
To document the incidence of PRS during LDLT and classify severity of PRSTimepoint: at the end of surgery

Secondary

MeasureTime frame
1.To identify the predictors of PRS.Timepoint: On Postoperative Day 30 or at discharge (whichever is first);2)To examine the postoperative consequences of PRS after LTTimepoint: On Postoperative Day 30 or at discharge (whichever is first)

Countries

India

Contacts

Public ContactDr Shweta A Singh

Max Super Speciality Hospital

drshwetasingh29@gmail.com9810625177

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026